Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis

ARHGAP6 Promotes Apoptosis and Inhibits Glycolysis in Lung Adenocarcinoma Through STAT3 Signaling Pathway

(2020) Pengfei Li et al.   Cancer Management and Research

Betacellulin drives therapy-resistance in glioblastoma

(2019) QiWen Fan et al.   NEURO-ONCOLOGY

Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signaling

(2019) Jianfang Zhao et al.   CELLULAR SIGNALLING

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Betacellulin (BTC) Biases the EGFR to Dimerize with ErbB3

(2018) Jamie S Rush et al.   MOLECULAR PHARMACOLOGY

Semaphorins and Their Receptors: From Axonal Guidance to Atherosclerosis

(2018) Shuhong Hu et al.   Frontiers in Physiology

Discordance of Mutation Statuses of Epidermal Growth Factor Receptor and K-ras between Primary Adenocarcinoma of Lung and Brain Metastasis

(2016) Kun-Ming Rau et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Betacellulin induces Slug-mediated down-regulation of E-cadherin and cell migration in ovarian cancer cells

(2016) Jianfang Zhao et al.   Oncotarget

The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer

(2016) Said Khelwatty et al.   Oncotarget

Regulatory mechanisms of betacellulin in CXCL8 production from lung cancer cells

(2014) Lin Shi et al.   Journal of Translational Medicine

Comprehensive molecular profiling of lung adenocarcinoma

(2014) Eric A. Collisson et al.   NATURE

The ABC of BTC: Structural properties and biological roles of betacellulin

(2014) Maik Dahlhoff et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Trafficking of Epidermal Growth Factor Receptor Ligands in Polarized Epithelial Cells

(2013) Bhuminder Singh et al.   Annual Review of Physiology

Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

(2013) Justin F. Gainor et al.   JOURNAL OF CLINICAL ONCOLOGY

Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers

(2012) Ramaswamy Govindan et al.   CELL

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

(2012) Cole Trapnell et al.   Nature Protocols

Lung Cancer: Epidemiology, Etiology, and Prevention

(2011) Charles S. Dela Cruz et al.   CLINICS IN CHEST MEDICINE

Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis

(2011) Mahmut Yilmaz et al.   EMBO JOURNAL

HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors

(2009) M. Sun et al.   CLINICAL CANCER RESEARCH

F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage

(2009) Manas K. Santra et al.   NATURE

Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition

(2009) A. C. Faber et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Somatic mutations affect key pathways in lung adenocarcinoma

(2008) Li Ding et al.   NATURE